Key result
Metabolic cardiovascular risk factors disrupt the post-myocardial infarction inflammatory response, highlighting the need for personalized therapeutic approaches and lifestyle modifications.
Why the study?
Excessive or uncontrolled post-MI inflammation leads to cardiovascular complications, necessitating an overview of local immune cascades and the disruptive role of metabolic risk factors.
Understanding the impact of metabolic risk factors on post-myocardial infarction inflammation may guide personalized therapeutic strategies and lifestyle modifications to improve cardiovascular outcomes.
Metabolic risk factors may modulate post-MI inflammation; leaves open whether targeting them alters healing or outcomes.
Myocardial infarction (MI) sets off a complex inflammatory cascade that is crucial for effective cardiac healing and scar formation. Yet, if this response becomes excessive or uncontrolled, it can lead to cardiovascular complications. This review aims to provide a comprehensive overview of the tightly regulated local inflammatory response triggered in the early post-MI phase involving cardiomyocytes, (myo)fibroblasts, endothelial cells, and infiltrating immune cells. Next, we explore how the bone marrow and extramedullary hematopoiesis (such as in the spleen) contribute to sustaining immune cell supply at a cardiac level. Lastly, we discuss recent findings on how metabolic cardiovascular risk factors, including hypercholesterolemia, hypertriglyceridemia, diabetes, and hypertension, disrupt this immunological response and explore the potential modulatory effects of lifestyle habits and pharmacological interventions. Understanding how different metabolic risk factors influence the inflammatory response triggered by MI and unraveling the underlying molecular and cellular mechanisms may pave the way for developing personalized therapeutic approaches based on the patient's metabolic profile. Similarly, delving deeper into the impact of lifestyle modifications on the inflammatory response post-MI is crucial. These insights may enable the adoption of more effective strategies to manage post-MI inflammation and improve cardiovascular health outcomes in a holistic manner.
No takes yet. Share an insight, caveat, or question.
Ramos-Regalado et al. (2024) conducted a review in Myocardial infarction. Metabolic risk factors was evaluated. Metabolic cardiovascular risk factors disrupt the post-myocardial infarction inflammatory response, highlighting the need for personalized therapeutic approaches and lifestyle modifications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: